96 related articles for article (PubMed ID: 32236582)
41. Expression of 17β-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer.
Frycz BA; Murawa D; Borejsza-Wysocki M; Marciniak R; Murawa P; Drews M; Jagodziński PP
Biomed Pharmacother; 2015 Mar; 70():24-7. PubMed ID: 25776474
[TBL] [Abstract][Full Text] [Related]
42. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
43. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
[TBL] [Abstract][Full Text] [Related]
44. Targeting the estrogen pathway for the treatment and prevention of lung cancer.
Burns TF; Stabile LP
Lung Cancer Manag; 2014 Feb; 3(1):43-52. PubMed ID: 25395992
[TBL] [Abstract][Full Text] [Related]
45. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
Labrie F
J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
[TBL] [Abstract][Full Text] [Related]
46. Women are more susceptible than men to oxidative stress and chromosome damage caused by polycyclic aromatic hydrocarbons exposure.
Guo H; Huang K; Zhang X; Zhang W; Guan L; Kuang D; Deng Q; Deng H; Zhang X; He M; Christiani D; Wu T
Environ Mol Mutagen; 2014 Jul; 55(6):472-81. PubMed ID: 24668722
[TBL] [Abstract][Full Text] [Related]
47. Xenoestrogens challenge 17β-estradiol protective effects in colon cancer.
Marino M
World J Gastrointest Oncol; 2014 Mar; 6(3):67-73. PubMed ID: 24653796
[TBL] [Abstract][Full Text] [Related]
48. Heavy smoking and lung cancer: are women at higher risk? Result of the ICARE study.
Papadopoulos A; Guida F; Leffondré K; Cénée S; Cyr D; Schmaus A; Radoï L; Paget-Bailly S; Carton M; Menvielle G; Woronoff AS; Tretarre B; Luce D; Stücker I
Br J Cancer; 2014 Mar; 110(5):1385-91. PubMed ID: 24423926
[TBL] [Abstract][Full Text] [Related]
49. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.
Győrffy B; Surowiak P; Budczies J; Lánczky A
PLoS One; 2013; 8(12):e82241. PubMed ID: 24367507
[TBL] [Abstract][Full Text] [Related]
50. Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor.
Verma MK; Miki Y; Abe K; Suzuki T; Niikawa H; Suzuki S; Kondo T; Sasano H
J Transl Med; 2013 Jul; 11():167. PubMed ID: 23837683
[TBL] [Abstract][Full Text] [Related]
51. Assessment of steroidogenesis and steroidogenic enzyme functions.
Luu-The V
J Steroid Biochem Mol Biol; 2013 Sep; 137():176-82. PubMed ID: 23770321
[TBL] [Abstract][Full Text] [Related]
52. Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer.
Jala VR; Radde BN; Haribabu B; Klinge CM
BMC Cancer; 2012 Dec; 12():624. PubMed ID: 23273253
[TBL] [Abstract][Full Text] [Related]
53. Conversion of estrone to 17-beta-estradiol in human non-small-cell lung cancer cells in vitro.
Drzewiecka H; Jagodzinski PP
Biomed Pharmacother; 2012 Oct; 66(7):530-4. PubMed ID: 22705334
[TBL] [Abstract][Full Text] [Related]
54. Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.
Jeong Y; Xie Y; Lee W; Bookout AL; Girard L; Raso G; Behrens C; Wistuba II; Gadzar AF; Minna JD; Mangelsdorf DJ
Mol Endocrinol; 2012 Aug; 26(8):1443-54. PubMed ID: 22700587
[TBL] [Abstract][Full Text] [Related]
55. The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cells.
Zhang CY; Chen J; Yin DC; Lin SX
PLoS One; 2012; 7(1):e29835. PubMed ID: 22253796
[TBL] [Abstract][Full Text] [Related]
56. Gender differences in susceptibility to smoking among patients with lung cancer.
Ryu JS; Jeon SH; Kim JS; Lee JH; Kim SH; Hong JT; Jeong JH; Jeong JJ; Lee MD; Min SJ; Nam HS; Cho JH; Kwak SM; Lee HL; Kim HJ
Korean J Intern Med; 2011 Dec; 26(4):427-31. PubMed ID: 22205843
[TBL] [Abstract][Full Text] [Related]
57. Aromatase in human lung carcinoma.
Verma MK; Miki Y; Sasano H
Steroids; 2011 Jul; 76(8):759-64. PubMed ID: 21392519
[TBL] [Abstract][Full Text] [Related]
58. Gender is a risk factor for lung cancer.
Gasperino J
Med Hypotheses; 2011 Mar; 76(3):328-31. PubMed ID: 21106301
[TBL] [Abstract][Full Text] [Related]
59. Estrogen receptor signaling in lung cancer.
Siegfried JM; Hershberger PA; Stabile LP
Semin Oncol; 2009 Dec; 36(6):524-31. PubMed ID: 19995644
[TBL] [Abstract][Full Text] [Related]
60. Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells.
Ivanova MM; Mazhawidza W; Dougherty SM; Klinge CM
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):320-30. PubMed ID: 19556604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
